XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021 19,517,988        
Beginning balance at Dec. 31, 2021 $ 171,833        
Ending balance (in shares) at Mar. 31, 2022 19,517,988        
Ending balance at Mar. 31, 2022 $ 171,833        
Beginning balance (in shares) at Dec. 31, 2021   2,972,409      
Beginning balance at Dec. 31, 2021 (111,457) $ 0 $ 3,619 $ 0 $ (115,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   172,606      
Exercise of common stock options 422   422    
Vesting of early exercise of common stock options (in shares)   143,524      
Vesting of early exercise of common stock options 375   375    
Stock-based compensation expense 661   661    
Net loss (11,808)       (11,808)
Ending balance (in shares) at Mar. 31, 2022   3,288,539      
Ending balance at Mar. 31, 2022 $ (121,807) $ 0 5,077 0 (126,884)
Beginning balance (in shares) at Dec. 31, 2021 19,517,988        
Beginning balance at Dec. 31, 2021 $ 171,833        
Ending balance (in shares) at Jun. 30, 2022 0        
Ending balance at Jun. 30, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021   2,972,409      
Beginning balance at Dec. 31, 2021 (111,457) $ 0 3,619 0 (115,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (23,360)        
Ending balance (in shares) at Jun. 30, 2022   43,368,270      
Ending balance at Jun. 30, 2022 $ 154,266 $ 4 292,698   (138,436)
Beginning balance (in shares) at Mar. 31, 2022 19,517,988        
Beginning balance at Mar. 31, 2022 $ 171,833        
Temporary Equity [Abstract]          
Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction cost (in shares) (19,517,988)        
Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction cost $ (171,833)        
Ending balance (in shares) at Jun. 30, 2022 0        
Ending balance at Jun. 30, 2022 $ 0        
Beginning balance (in shares) at Mar. 31, 2022   3,288,539      
Beginning balance at Mar. 31, 2022 (121,807) $ 0 5,077 0 (126,884)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of common stock options (in shares)   27,233      
Exercise of common stock options 74   74    
Vesting of early exercise of common stock options (in shares)   41,047      
Vesting of early exercise of common stock options 102   102    
Stock-based compensation expense 9,225   9,225    
Net loss (11,552)       (11,552)
Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction costs (in shares)   19,517,988      
Conversion of redeemable convertible preferred stock into common stock in connection with the Reverse Recapitalization, net of transaction cost 171,835 $ 2 171,833    
Issuance of common stock upon Reverse Recapitalization, net of transaction costs (in shares)   19,975,963      
Issuance of common stock upon Reverse Recapitalization, net of transaction costs 112,182 $ 2 112,180    
Contingent earnout liability recognized upon closing of the Reverse Recapitalization (9,688)   (9,688)    
Cancellation and exchange of convertible note in connection with PIPE financing (in shares)   517,500      
Cancellation and exchange of convertible note in connection with PIPE financing 5,184   5,184    
Gain recognized on fair value of embedded derivative on SPAC merger date (1,289)   (1,289)    
Ending balance (in shares) at Jun. 30, 2022   43,368,270      
Ending balance at Jun. 30, 2022 $ 154,266 $ 4 292,698   (138,436)
Beginning balance (in shares) at Dec. 31, 2022 0        
Beginning balance at Dec. 31, 2022 $ 0        
Ending balance (in shares) at Mar. 31, 2023 0        
Ending balance at Mar. 31, 2023 $ 0        
Beginning balance (in shares) at Dec. 31, 2022 44,062,534 44,062,534      
Beginning balance at Dec. 31, 2022 $ 127,263 $ 4 300,544 1 (173,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of early exercise of common stock options (in shares)   12,660      
Vesting of early exercise of common stock options 34   34    
Stock-based compensation expense 3,763   3,763    
Net loss (18,722)       (18,722)
Unrealized gain (loss) on investments 2     2  
Ending balance (in shares) at Mar. 31, 2023   44,075,194      
Ending balance at Mar. 31, 2023 $ 112,340 $ 4 304,341 3 (192,008)
Beginning balance (in shares) at Dec. 31, 2022 0        
Beginning balance at Dec. 31, 2022 $ 0        
Ending balance (in shares) at Jun. 30, 2023 0        
Ending balance at Jun. 30, 2023 $ 0        
Beginning balance (in shares) at Dec. 31, 2022 44,062,534 44,062,534      
Beginning balance at Dec. 31, 2022 $ 127,263 $ 4 300,544 1 (173,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (37,419)        
Ending balance (in shares) at Jun. 30, 2023 44,465,006 44,465,006      
Ending balance at Jun. 30, 2023 $ 97,416 $ 4 308,117 0 (210,705)
Beginning balance (in shares) at Mar. 31, 2023 0        
Beginning balance at Mar. 31, 2023 $ 0        
Ending balance (in shares) at Jun. 30, 2023 0        
Ending balance at Jun. 30, 2023 $ 0        
Beginning balance (in shares) at Mar. 31, 2023   44,075,194      
Beginning balance at Mar. 31, 2023 112,340 $ 4 304,341 3 (192,008)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of early exercise of common stock options (in shares)   12,660      
Vesting of early exercise of common stock options 34   34    
Issuance of common stock under Employee Stock Purchase Plan (ESPP) (in shares)   377,152      
Issuance of common stock under Employee Stock Purchase Plan (ESPP) 308   308    
Stock-based compensation expense 3,434   3,434    
Net loss (18,697)       (18,697)
Unrealized gain (loss) on investments $ (3)     (3)  
Ending balance (in shares) at Jun. 30, 2023 44,465,006 44,465,006      
Ending balance at Jun. 30, 2023 $ 97,416 $ 4 $ 308,117 $ 0 $ (210,705)